An interesting advancement in an MS stem cell study for those interested in the many applications overnight:
An international team has conducted a groundbreaking study on stem cell therapy for progressive multiple sclerosis (MS).The therapy, involving the injection of neural stem cells into patients’ brains, was found to be safe and potentially effective in preventing further brain damage. This innovative approach, tested in a small-scale trial, offers hope for stabilizing the debilitating progression of MS.
https://neurosciencenews.com/stem-cells-multiple-sclerosis-25257/
More and quite big news on the stem cell research back drop, but not as related to OCC as the many autologous regulatory developments, but the acceptance ever building.
An interesting advancement in an MS stem cell study for those...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.030(8.11%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.5¢ | 38.5¢ | $284.0K | 720.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22248 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 208719 | 7 |
View Market Depth
| Last trade - 15.58pm 11/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |